PMID- 16551679 OWN - NLM STAT- MEDLINE DCOM- 20060810 LR - 20231213 IS - 0741-5400 (Print) IS - 0741-5400 (Linking) VI - 79 IP - 6 DP - 2006 Jun TI - IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. PG - 1279-85 AB - Dendritic cells (DCs) play an important role in innate and adaptive immune responses. In addition to their phagocytic activity, DCs present foreign antigens to naive T cells and regulate the development of adaptive immune responses. Upon contact with DCs, activated T cells produce large quantities of cytokines such as interferon-gamma (IFN-gamma) and interleukin (IL)-21, which have important immunoregulatory functions. Here, we have analyzed the effect of IL-21 and IFN-gamma on lipopolysaccharide (LPS)-induced maturation and cytokine production of human monocyte-derived DCs. IL-21 and IFN-gamma receptor genes were expressed in high levels in immature DCs. Pretreatment of immature DCs with IL-21 inhibited LPS-stimulated DC maturation and expression of CD86 and human leukocyte antigen class II (HLAII). IL-21 pretreatment also dramatically reduced LPS-stimulated production of tumor necrosis factor alpha, IL-12, CC chemokine ligand 5 (CCL5), and CXC chemokine ligand 10 (CXCL10) but not that of CXCL8. In contrast, IFN-gamma had a positive feedback effect on immature DCs, and it enhanced LPS-induced DC maturation and the production of cytokines. IL-21 weakly induced the expression Toll-like receptor 4 (TLR4) and translation initiation region (TIR) domain-containing adaptor protein (TIRAP) genes, whereas the expression of TIR domain-containing adaptor-inducing IFN-beta (TRIF), myeloid differentiation (MyD88) 88 factor, or TRIF-related adaptor molecule (TRAM) genes remained unchanged. However, IL-21 strongly stimulated the expression of suppressor of cytokine signaling (SOCS)-1 and SOCS-3 genes. SOCS are known to suppress DC functions and interfere with TLR4 signaling. Our results demonstrate that IL-21, a cytokine produced by activated T cells, can directly inhibit the activation and cytokine production of myeloid DCs, providing a negative feedback loop between DCs and T lymphocytes. FAU - Strengell, Mari AU - Strengell M AD - Department of Viral Diseases and Immunology, National Public Health Institute, Mannerheimintie 166, FIN-00300 Helsinki, Finland. mari.strengell@ktl.fi FAU - Lehtonen, Anne AU - Lehtonen A FAU - Matikainen, Sampsa AU - Matikainen S FAU - Julkunen, Ilkka AU - Julkunen I LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060321 PL - England TA - J Leukoc Biol JT - Journal of leukocyte biology JID - 8405628 RN - 0 (CCL5 protein, human) RN - 0 (Chemokine CCL5) RN - 0 (Chemokines, CC) RN - 0 (Chemokines, CXC) RN - 0 (Cytokines) RN - 0 (HLA-DR Antigens) RN - 0 (IL21R protein, human) RN - 0 (Interleukin-21 Receptor alpha Subunit) RN - 0 (Interleukins) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Lipopolysaccharides) RN - 0 (Membrane Glycoproteins) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Interferon) RN - 0 (Receptors, Interleukin) RN - 0 (Receptors, Interleukin-1) RN - 0 (Receptors, Interleukin-21) RN - 0 (Recombinant Proteins) RN - 0 (Repressor Proteins) RN - 0 (SOCS1 protein, human) RN - 0 (SOCS3 protein, human) RN - 0 (Suppressor of Cytokine Signaling 1 Protein) RN - 0 (Suppressor of Cytokine Signaling 3 Protein) RN - 0 (Suppressor of Cytokine Signaling Proteins) RN - 0 (TIRAP protein, human) RN - 0 (TLR4 protein, human) RN - 0 (Toll-Like Receptor 4) RN - 0 (Tumor Necrosis Factor-alpha) RN - 187348-17-0 (Interleukin-12) RN - 82115-62-6 (Interferon-gamma) RN - MKM3CA6LT1 (interleukin-21) SB - IM MH - Cell Communication MH - Cells, Cultured/drug effects/immunology/metabolism MH - Chemokine CCL5 MH - Chemokines, CC/biosynthesis/genetics MH - Chemokines, CXC/biosynthesis/genetics MH - Cytokines/*biosynthesis/genetics MH - Dendritic Cells/*drug effects/immunology/metabolism MH - Feedback, Physiological MH - Gene Expression Profiling MH - Gene Expression Regulation/*drug effects MH - HLA-DR Antigens/biosynthesis MH - Humans MH - Interferon-gamma/pharmacology MH - Interleukin-12/biosynthesis/genetics MH - Interleukin-21 Receptor alpha Subunit MH - Interleukins/*pharmacology/physiology MH - Intracellular Signaling Peptides and Proteins/genetics MH - Lipopolysaccharides/antagonists & inhibitors MH - Lymphocyte Activation MH - Macrophages/drug effects/metabolism MH - Membrane Glycoproteins/biosynthesis/genetics MH - RNA, Messenger/biosynthesis/genetics MH - Receptors, Interferon/biosynthesis/genetics MH - Receptors, Interleukin/biosynthesis/genetics MH - Receptors, Interleukin-1/biosynthesis/genetics MH - Receptors, Interleukin-21 MH - Recombinant Proteins/pharmacology MH - Repressor Proteins/*biosynthesis/genetics MH - Suppressor of Cytokine Signaling 1 Protein MH - Suppressor of Cytokine Signaling 3 Protein MH - Suppressor of Cytokine Signaling Proteins/*biosynthesis/genetics MH - T-Lymphocytes/immunology/*metabolism MH - Toll-Like Receptor 4/biosynthesis/genetics MH - Tumor Necrosis Factor-alpha/biosynthesis/genetics MH - Interferon gamma Receptor EDAT- 2006/03/23 09:00 MHDA- 2006/08/11 09:00 CRDT- 2006/03/23 09:00 PHST- 2006/03/23 09:00 [pubmed] PHST- 2006/08/11 09:00 [medline] PHST- 2006/03/23 09:00 [entrez] AID - jlb.0905503 [pii] AID - 10.1189/jlb.0905503 [doi] PST - ppublish SO - J Leukoc Biol. 2006 Jun;79(6):1279-85. doi: 10.1189/jlb.0905503. Epub 2006 Mar 21.